entity

Adcs

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Adcs: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
0Analyses
1Outgoing
0Incoming

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

ADCS-MCI-ADL (Alzheimer's Disease Cooperative Study — Activities of Daily Living, Mild Cognitive Impairment)

scale · 615 words

neuroinflammation

mechanism · 5462 words

omega-3-fatty-acids-neurodegeneration

therapeutic · 4551 words

Melatonin for Tauopathy: Comprehensive Evidence Synthesis

therapeutic · 4539 words

dimethyl-fumarate-nrf2-ad-nct06850597

clinical_trial · 4373 words

A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

clinical · 4279 words

Outgoing (1)

TargetRelationTypeStr
BCL2targetsprotein0.85

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found